BioTuesdays

Category - Markets

Gritstone Oncology
Markets

HCW starts Gritstone Oncology at buy; PT $17

H.C. Wainwright launched coverage of Gritstone Oncology (NASDAQ:GRTS) with a “buy” rating and $17 price target. The stock closed at $11.64 on March 6. Gritstone is focused on developing novel neoantigen-targeting...

March 7, 2019
T2 Biosystems Logo
Markets

Canaccord recommends buying T2 Biosystems on weakness

Canaccord Genuity reiterated its “buy” rating and $10 price target for T2 Biosystems (NASDAQ:TTOO), saying, “We would buy on weakness.” The stock was quoted at $3.71, down 58 cents, or 13%, in afternoon trading on March...

March 5, 2019
Markets

SVB Leerink starts MannKind at OP; PT $3

SVB Leerink initiated coverage of MannKind (NASDAQ:MNKD) with an “outperform” rating and a 12-month price target of $3. The stock closed at $1.77 on March 1. Analyst Dr. Pasha Sarraf writes that his rating is based on...

March 4, 2019
OpGen Logo
Markets

AGP starts OpGen at buy; PT $2.30

AGP/Alliance Global Partners launched coverage of OpGen (NASDAQ:OPGN) with a “buy” rating and price target of $2.30. The stock closed at $1.48 on March 1. “OpGen’s approach to antibiotic resistance identification...

March 4, 2019
Albireo Pharma Logo
Markets

HCW starts Albireo Pharma at buy; PT $62

H.C. Wainwright launched coverage of Albireo Pharma (NASDAQ:ALBO) with a “buy” rating and $27 price target. The stock closed at $26.80 on Feb. 27. Albireo is focused on rare pediatric and adult cholestatic diseases...

February 28, 2019
Corindus Logo
Markets

Corindus Vascular Robotics closes private placement

Corindus Vascular Robotics (NYSE American:CVRS) privately sold 10,872,716 of its common shares at a price of $1.3796 each to a large institutional investor for gross proceeds of about $15-million. Net proceeds of about...

February 26, 2019